Jazz Pharmaceuticals (JAZZ) EPS (Basic) Growth (1y) (2011 - 2026)
Jazz Pharmaceuticals (JAZZ) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn | 412.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 412.61% |
| Dec 31, 2025 | 7.97% |
| Sep 30, 2025 | 18.14% |
| Jun 30, 2025 | -537.75% |
| Mar 31, 2025 | -547.60% |
| Dec 31, 2024 | 106.75% |
| Sep 30, 2024 | 50.83% |
| Jun 30, 2024 | 61.76% |
| Mar 31, 2024 | -121.09% |
| Dec 31, 2023 | 138.97% |
| Sep 30, 2023 | 952.03% |
| Jun 30, 2023 | 178.89% |
| Mar 31, 2023 | 1,085.32% |
| Dec 31, 2022 | -607.71% |
| Sep 30, 2022 | 66.24% |
| Jun 30, 2022 | 109.69% |
| Mar 31, 2022 | -95.51% |
| Dec 31, 2021 | -122.52% |
| Sep 30, 2021 | -130.16% |
| Jun 30, 2021 | -391.27% |